8JH7 image
Deposition Date 2023-05-22
Release Date 2024-01-17
Last Version Date 2025-07-02
Entry Detail
PDB ID:
8JH7
Title:
FZD6 in inactive state
Biological Source:
Source Organism:
Host Organism:
Method Details:
Experimental Method:
Resolution:
3.20 Å
Aggregation State:
PARTICLE
Reconstruction Method:
SINGLE PARTICLE
Macromolecular Entities
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Frizzled-6,Soluble cytochrome b562
Gene (Uniprot):FZD6, cybC
Chain IDs:D
Chain Length:641
Number of Molecules:1
Biological Source:Homo sapiens, Escherichia coli
Polymer Type:polypeptide(L)
Molecule:anti-BRIL Fab Heavy chain
Chain IDs:A (auth: H)
Chain Length:240
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:anti-Fab Nanobody
Chain IDs:B (auth: K)
Chain Length:127
Number of Molecules:1
Biological Source:synthetic construct
Polymer Type:polypeptide(L)
Molecule:anti-BRIL Fab Light chain
Chain IDs:C (auth: L)
Chain Length:212
Number of Molecules:1
Biological Source:Homo sapiens
Ligand Molecules
Primary Citation
A framework for Frizzled-G protein coupling and implications to the PCP signaling pathways.
Cell Discov 10 3 3 (2024)
PMID: 38182578 DOI: 10.1038/s41421-023-00627-y

Abstact

The ten Frizzled receptors (FZDs) are essential in Wnt signaling and play important roles in embryonic development and tumorigenesis. Among these, FZD6 is closely associated with lens development. Understanding FZD activation mechanism is key to unlock these emerging targets. Here we present the cryo-EM structures of FZD6 and FZD3 which are known to relay non-canonical planar cell polarity (PCP) signaling pathways as well as FZD1 in their G protein-coupled states and in the apo inactive states, respectively. Comparison of the three inactive/active pairs unveiled a shared activation framework among all ten FZDs. Mutagenesis along with imaging and functional analysis on the human lens epithelial tissues suggested potential crosstalk between the G-protein coupling of FZD6 and the PCP signaling pathways. Together, this study provides an integrated understanding of FZD structure and function, and lays the foundation for developing therapeutic modulators to activate or inhibit FZD signaling for a range of disorders including cancers and cataracts.

Legend

Protein

Chemical

Disease

Primary Citation of related structures